Radon is a naturally occurring radioactive gas produced by the breakdown of uranium in soil, rocks and water. Since the air pressure in a typical home is lower than the pressure in the soil around the foundation, the home acts like a vacuum and draws radon in through cracks in the foundation.
Radon exposure can have detrimental effects on both your own and your family’s health—elevating the risk for complications such as lung cancer. With this in mind, consider the following guidance to help eliminate radon dangers in your home.
When to Test for Radon
According to the Environmental Protection Agency (EPA), radon gas levels can vary by day, season and geographic area. The EPA recommends testing for radon if:
- The home was never tested.
- The home hasn’t been tested in more than two years.
- The home has been renovated since it was last tested.
- You plan to occupy a lower level of the home than what was originally tested, such as the basement.
How to Test for Radon
To test a home for radon, you can order a kit by mail from a qualified radon measurement service provider, purchase a radon kit from a local hardware store or hire a qualified radon tester (often also a home inspector).
If a radon test reveals that your home’s level is dangerous, you can install a radon mitigation system. A qualified radon reduction contractor can often install a system in less than a day. If your home’s water source has high levels of radon as well, a point-of-entry treatment device can be installed to reduce emissions.
The Risks of Radon Exposure
The National Cancer Institute reports that radon exposure is the second-leading cause of lung cancer in the United States. Ensure that your family is breathing easy by testing for radon and installing a radon mitigation system if the gas levels in your home are too high.
For more home safety guidance and homeowners insurance solutions, contact INSURICA today.
This article is provided for informational purposes only. The information provided herein is not intended to be exhaustive, nor should it be construed as advice regarding coverage. Eligibility for coverage is not guaranteed and all coverages are limited to the terms and conditions contained in the applicable policy. © 2026 Zywave, Inc. All rights reserved.
About the Author
Share This Story
Related Blogs
RxDC Reporting: What Employers Should Do Before the June 1 Deadline
Each year, group health plans must report detailed prescription drug and healthcare spending data to the Centers for Medicare & Medicaid Services (CMS). This reporting—commonly referred to as RxDC reporting—is due by June 1 and applies to most employer-sponsored group health plans that offer prescription drug coverage.
Chronic Condition Management 2.0: GLP-1 Alternatives and New Digital Therapeutics
Chronic conditions have long been the primary driver of employer healthcare spending, but 2026 marks a turning point in how organizations are approaching prevention, treatment, and long-term management. With GLP-1 medications dominating headlines — and budgets — employers are urgently exploring complementary or alternative strategies that can improve outcomes without unsustainable cost growth. The result is a new wave of digital therapeutics, metabolic health programs, and integrated care models that promise a more balanced approach to chronic disease management.
The Return-to-Office Reset: How Benefits Are Being Re-Engineered in 2026
After several years of experimentation, many employers are tightening hybrid schedules or requiring more in-office days. This “return-to-office reset” is reshaping benefits strategies as organizations look for ways to support commuting employees, improve onsite experience, and maintain flexibility. What began as a workplace policy shift is now driving a broader rethinking of how benefits can reinforce culture, productivity, and retention.